TScan <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc. to Present at American Society of Gene and Cell Therapy Annual Meeting
TScan Therapeutics Inc., a clinical-stage biotechnology company, will attend the American Society of Gene and Cell Therapy 28th Annual Meeting from May 13 to 17 in New Orleans, LA, and virtually. They will present a poster titled "CD45 as a Universal Target for Adjuvant TCR-T Cell Therapy Following Allogeneic Hematopoietic Cell Transplantation" on May 13.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TScan Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9440435-en) on April 28, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。